Serum levels and polymorphisms of matrix metalloproteinases (MMPs) in carotid artery atherosclerosis: Higher MMP-9 levels are associated with plaque vulnerability

Biomarkers

Volumn 19, Issue 1, 2014, Pages 49-55

  Silvello, Daiane ^a   Narvaes, Luciane Barreneche ^b   Albuquerque, Luciano Cabral ^b   Forgiarini, Luiz Felipe ^a   Meurer, Luise ^a   Martinelli, Nidiane Carla ^a   Andrades, Michael Everton ^a   Clausell, Nadine ^a   Santos, Kátia Gonçalves Dos ^a,c   Rohde, Luis Eduardo ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c UNIVERSIDADE LUTERANA DO BRASIL   (Brazil)

Author keywords

Atheroma; Biomarker; Inflammation

Indexed keywords

GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; STROMELYSIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLEEDING; BLOOD LEVEL; CAROTID ATHEROSCLEROSIS; CAROTID ENDARTERECTOMY; CEREBROVASCULAR ACCIDENT; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL VASCULAR DISEASE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

AGED; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84893318842     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2013.866165     Document Type: Article

References (32)

1. Albuquerque LC, Narvaes LB, Maciel AA, et al. (2007). Intraplaque hemorrhage assessed by high-resolution magnetic resonance and C-reactive protein in carotid atherosclerosis. J Vasc Surg 46:1130-7.
2. Alvarez B, Ruiz C, Chacón P, et al. (2004). Serum values of metalloproteinase-2 and metalloproteinase-9 as related to unstable plaque and inflammatory cells in patients with greater than 70% carotid artery stenosis. J Vasc Surg 40:469-75.
3. Barnett HJ, Taylor DW, Eliasziw M, et al. (1998). Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid E ndarterectomy Trial Collaborators. N Engl J Med 339:1415-25.
4. Blankenberg S, Rupprecht HJ, Poirier O, et al. (2003). AtheroGene Investigators: Plasma concentrations and genetic variation of matrix metall oproteinase 9 and prognosis of patients with cardiovascular disease. Circulation 107:1579-85.
5. Choudhary S, Higgins CL, Chen IY, et al. (2006). Quantitation and localization of matrix metalloproteinases and their inhibitors in human carotid endarterectomy tissues. Arterioscler Thromb Vasc Biol 26: 2351-8.
6. De Nooijer R, Verkleij CJ, von Der Thusen JH, et al. (2006). Lesional overexpression of matrix met alloproteinase-9 promotes intraplaque hemorrhage in advanced lesions but not at earlier stages of atherogenesis. Arterioscl Thromb Vasc Biol 26:340-6.
7. Devuyst G, Karapanayiotides T, Ruchat P, et al. (2005). Ultrasound measurement of the fibrous cap in symptomatic and asymptomatic atheromatous carotid plaques. Circulation 111:2776-82.
8. Ding S, Zhang M, Zhao Y, et al. (2008). The role of carotid plaque v ulnerability and inflammation in the pathogenesis of acute ischemic stroke. Am J Med Sci 336:27-31.
9. Djurić T, Stojković L, Zivković M, et al. (2012). Matrix metalloproteinase-1 promoter genotypes and haplotypes are associated with carotid plaque presence. Clin Biochem 45:1353-6.
10. Djurić T, Zivković M, Radak D, et al. (2008). Association of MMP-3 5A/6A gene polymorphism with susceptibility to carotid atherosclerosis. Clin Biochem 41:1326-9.
11. Dunleavey L, Beyzade S, Ye S. (2000a ). Rapid genotype analysis of the matrix metalloproteinase-1 gene 1G/2G polymorphism that is associated with risk of cancer. Matrix Biol 19:175-7.
12. Dunleavey L, Beyzade S, Ye S. (2000b ). Rapid genotype analysis of the stromelysin gene 5A/6A polymorphism. Atherosclerosis 151:587-9.
13. Eldrup N, Gronholdt MM, Sillesen H, et al. (2006). Elevated matrix metalloproteinase-9 as sociated with stroke or cardiovascular death in patients with carotid stenosis. Circulation 114:1847-54.
14. Fiotti N, Moretti ME, Bussani R, et al. (2011). Features of vulnerable plaques and clinical outcome o f UA/NSTEMI. Relationship with matrix metalloproteinase functional polymorphisms. Atherosclerosis 215:153-9.
15. Ghaderian SM, Akbarzadeh Najar R, Tabatabaei Panah AS. (2010). Genetic polymorphisms and plasma level s of matrix metalloproteinases and their relationships with developing acute myocardial infarction. Coron Artery Dis 21:330-5.
16. Ghilardi G, Biondi ML, DeMonti M, et al. (2002). Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with carotid artery stenosis. Stroke 33:2408-12.
17. Goldstein LB, Adams R, Alberts MJ, et al. (2006). American Heart Association/A merican Stroke Association Stroke Council; Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; Quality of Care and O utcomes Research Interdisciplinary Working Group; and American Academy of Neurology: Primary prevention of ischemic stroke: A guideline from the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peri p heral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The A merican Academy of Neurology affirms the value of this guideline. Stroke 37:1583-633.
18. Heo SH, Cho CH, Kim HO, et al. (2011). Plaque rupture is a determinant of vascular events in carotid artery atherosclerot ic disease: Involvement of matrix metalloproteinases 2 and 9. J Clin Neurol 7:69-76.
19. Ketelhuth DF, Ba?ck M. (2011). The role of matrix metalloproteinases in atherothrombosis. Curr Atheroscler Rep 13:162-9.
20. Kunte H, Kunte G, Busch MA, et al. (2010). Differences in carotid plaque content of macrophages, T cells and MMP-9 between patients with embolic and hemodynamic cerebral ischemia due to symptomatic carotid stenosis . Atherosclerosis 211:456-60.
21. Lahiri DK, Nurnberger JI. (1991). A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 19:5444.
22. Libby P, Ridker PM, Hansson GK. (2011). Progress and challenges in translating the biology of atherosclerosis. Nature 473:317-25.
23. Lien LM, Hsieh YC, Bai CH, et al. (2010). Association of blo od active matrix metalloproteinase-3 with carotid plaque score from a community population in Taiwan. Atherosclerosis 212:595-600.
24. Loftus IM, Naylor AR, Goodall S, et al. (2000). Increased matrix metalloproteinase-9 activity in unstable carotid plaques. A potential role in acute plaque disruption. Stroke 31:40-7.
25. Moody AR, Murphy RE, Morgan PS, et al. (2003). Characterization of complicated carotid plaque with magnetic resonance: Direct thrombus imaging in patients with cerebral ischemia. Circulation 107:3047-52.
26. Nanni S, Melan dri G, Hanemaaijer R, et al. (2007). Matrix metalloproteinases in premature coronary atherosclerosis: Influence of inhibitors, inflammation, and genetic polymorphisms. Transl Res 149:137-44.
27. Nederkoorn PJ, Van Der Graaf Y, Hunink MG. (2003). Duplex ultrasound and magnetic resonance angiography compared with digital subtraction angiography in carotid artery stenosis: A systematic review. Stroke 34:1324-32.
28. Po?lla? nen PJ, Karhunen PJ, Mikkelsson J, et al. (2001). Coronary artery complicated lesion area is related to functional polymorphisms of matrix metalloproteinase 9 gene: An autopsy study. Arterioscler Thromb Vasc Biol 21:1446-50.
29. Po?lla?nen PJ, Lehtima? ki T, Mikkelsson J, et al. (2005). Matrix metalloproteinase 3 and 9 gene promoter polymorphisms: Joint action of two loci as a risk factor for coronary artery complicated plaques. Atherosclerosis 180:73-8.
30. Rauramaa R, Vaisanen SB, Luong LA, et al. (2000). Stromelysin-1 and interleukin-6 gene promoter polymorphisms are determinants of asymptomatic carotid artery atherosclerosis. A rterioscler Thromb Vasc Biol 20:2657-62.
31. Vercelino R, Crespo I, De Souza GF, et al. (2010). S-nitroso-N- acetylcysteine attenuates liver fibrosis in cirrhotic rats. J Mol Med 88:401-11.
32. Zhang B, Ye S, Herrmann SM, et al. (1999). Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation 99:1788-94.